Bioniq, a London, UK-based nutritional supplements company based on blood biomarker data, raised over €1M investment from Manchester United’s Diogo Dalot.
Dalot joined the global football icon Cristiano Ronaldo, who became a major investor in 2024, and brought Bioniq’s total valuation to $82M.
The company intends to use the funds to expand operations and its business reach.
Led by CEO and Founder Vadim Fedotov, Bioniq specializes in offering AI-driven personalized supplements based on blood test data. After conducting years of testing, it has developed a proprietary biochemical database with blood test data from customers across 5 continents. Shipping globally, the company has created formulas for over 300,000 users that incorporate components and dosages to each individual’s nutrient deficiencies, as identified through their blood results.
The news followed a Series B round, which raised $15M, led by Principal Investors HV Capital and Unbound, two leading European VCs.
FinSMEs
18/03/2025